Erratum: Schedule-dependent activity of irinotecan plus BCNU against malignant glioma xenografts (Cancer Chemotherapy and Pharmacology 45 (345- 349))

H. S. Friedman, R. C. Castellino, G. B. Elion, S. T. Keir, P. J. Houghton, S. P. Johnson, D. D. Bigner

Research output: Contribution to journalComment/debatepeer-review

Fingerprint Dive into the research topics of 'Erratum: Schedule-dependent activity of irinotecan plus BCNU against malignant glioma xenografts (Cancer Chemotherapy and Pharmacology 45 (345- 349))'. Together they form a unique fingerprint.